INBSINTELLIGENT BIO SOLUTIONS INC.

Nasdaq gbs.inc


$ 2.18 $ -0.29 (-11.69 %)    

Wednesday, 18-Sep-2024 15:59:11 EDT
QQQ $ 481.55 $ 0.00 (0 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 239.11 $ 0.00 (0 %)
$ 2.19
$ 2.04 x 100
$ 2.27 x 100
-- - --
$ 1.00 - $ 16.44
621,781
na
9.31M
$ 2.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-18-2024 06-30-2024 10-K
2 05-08-2024 03-31-2024 10-Q
3 02-09-2024 12-31-2023 10-Q
4 11-08-2023 09-30-2023 10-Q
5 08-23-2023 06-30-2023 10-K
6 05-11-2023 03-31-2023 10-Q
7 02-14-2023 12-31-2022 10-Q
8 11-14-2022 09-30-2022 10-Q
9 09-22-2022 06-30-2022 10-K
10 05-16-2022 03-31-2022 10-Q
11 02-10-2022 12-31-2021 10-Q
12 11-12-2021 09-30-2021 10-Q
13 09-16-2021 06-30-2021 10-K
14 05-13-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intelligent-bio-solutions-inc--entered-into-at-market-offering-agreement-with-ladenburg-thalmann--co

-Reuters

 whats-going-on-with-opiate-screening-tests-focused-intelligent-bio-solutions-stock-on-monday

Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The comp...

 intelligent-bio-solutions-shares-preliminary-q4-revenue-of-730k-fy24-revenue-of-311m

- 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respe...

 intelligent-bio-solutions-to-implement-strategic-reorganization-plan-to-support-global-growth-initiatives

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION